OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
3
Results
Show all
Save search
Copy query
Show results for
Unknown
(3)
Publication Date
Release Date
2023
(2)
2021
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Xanthine-Dopamine Hybrid Molecules as Multitarget Drugs with Potential for the Treatment of Neurodegenerative Diseases.
Not available
S-EPMC10377586
|
biostudies-literature
Cite
The Phenoxyalkyltriazine Antagonists for 5-HT
6
Receptor with Promising Procognitive and Pharmacokinetic Properties In Vivo in Search for a Novel Therapeutic Approach to Dementia Diseases.
Not available
S-EPMC8509428
|
biostudies-literature
Cite
Superiority of the Triple-Acting 5-HT
6
R/5-HT
3
R Antagonist and MAO-B Reversible Inhibitor
PZ-1922
over 5-HT
6
R Antagonist Intepirdine in Alleviation of Cognitive Deficits in Rats.
Not available
S-EPMC10641814
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets